Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biologics
Biotech
‘Why We Vaccinate’: BIO targets lawmakers for immunization push
As disinformation skyrockets, BIO is hoping to set the record straight, rolling out a campaign highlighting the value of vaccines.
Gabrielle Masson
Oct 20, 2025 1:50pm
Hansoh, Chugai ink separate and lucrative licensing agreements
Oct 17, 2025 11:04am
Astellas turns down option to license Taysha gene therapy—again
Oct 17, 2025 10:50am
Kite puts $1.64B on the line for Pregene's in vivo CAR-Ts
Oct 16, 2025 4:56pm
'Let that one go': Nkarta CEO urges US gov to drop China regs
Oct 16, 2025 2:00pm
Regeneron shares updated data on hearing loss gene therapy
Oct 12, 2025 10:18am